The role of arginine vasopressin (AVP) in the regulation of renal medullary blood flow is uncertain. To determine if AVP has a direct vasoconstrictive action on vasa recta, the effect of AVP on erythrocyte velocity (VRC), diameter, and blood flow (QvR) in descending vasa recta (DVR) and ascending vasa recta (AVR) was studied in the exposed renal papilla of four groups of chronically water diuretic rats using fluorescence videomicroscopy. There were three periods: control (period 1), experimental (period 2), and recovery (period 3). In periods 1 and 3, all groups received hypotonic saline. In 
Introduction
The actions of arginine vasopressin (AVP)' have been related to two distinct intracellular mechanisms (1) . First, vasopressor and glycogenolytic activities of AVP are associated with an increase in intracellular calcium concentration and phosphatidyl-inositol metabolism; second, antidiuretic activity is associated with an increase in intracellular cyclic AMP (cAMP) generation. In analogy to adrenergic and histaminergic receptors, Michell et al. (2) proposed that the reactions related to the phosphatidyl-inositol pathway be designated V,, and those related to cAMP as V2. Recently potent selective inhibitors to VI-related actions of AVP have been synthesized (3).
Thurau et al. (4) reported more than two decades ago that vasopressin in physiological amounts decreases inner medullary blood flow without affecting total renal blood or cortical blood flow. It was unclear, however, if the change in medullary flow was a consequence of a direct action of the hormone on vascular receptors (i.e., V1-receptor-mediated action), or indirectly a consequence of its antidiuretic activity, V2. This uncertainty was in part a consequence of the technical limitations in investigating medullary blood flow. While unphysiologically high doses of AVP directly reduce blood flow in both cortex and medulla, several investigators have failed to observe an effect on renal blood flow using physiological amounts of AVP (5) . We recently adapted videomicroscopy to study blood flow in the renal papilla. This method combined with modern fluorescence techniques (6) allows a continuous and quantitative measurement of blood flow in the exposed renal papilla in the rat (7, 8) .
The purposes of the present investigation were to determine, first, if AVP in physiological doses affects vasa recta blood flow (QvR) and, if so, whether this effect is mediated directly by the VI-receptor or indirectly by a V2-receptor.
Methods
Preparation of animals. Young Munich-Wistar rats (n = 37) of both sexes weighing between 93 and 188 g were prepared for videomicroscopy as described previously (9) . In brief, the animals received standard rat chow and were kept in a state of water diuresis for 2-4 wk by adding 5% dextrose to the tap water. On the afternoon before the experiment the animals were deprived of food and sustained on tap water containing 5% dextrose and 0.15% NaCl (10). Rats were anesthetized intraperitoneally with Inactin (thiobutabarbital; Byk Gulden, Konstanz, FRG) at 120 mg/kg body weight (BW). The trachea was cannulated and a triple lumen catheter, made of PE 50 tubing that was tapered by pulling the catheter over an alcohol flame, was inserted into the jugular vein. A PE 50 catheter was inserted into the left femoral artery for continuous recording of arterial blood pressure and for withdrawal of blood samples. A PE 50 catheter was inserted into the bladder for collection of urine. The body temperature was kept at 37.50C with the aid of a feedback-controlled heating table. The left kidney was exposed by a flank incision and carefully isolated from the perirenal tissue. The tissue around the renal pedicle was removed by dissection and the papilla was exposed by excising the ureter (1 1). The kidney was placed gently in a lucite holder, protected with small cotton balls, and the dorsal aspect of the papilla was displayed. Care was taken not to stretch the renal artery. Any ischemia of the kidney caused the experiment to be discarded. To prevent drying, the kidney was bathed in warm mineral oil and covered with a translucent foil (Saran Wrap) until microscopic observations were performed. During the video recording the foil was removed. After insertion of the arterial catheter, a sample of plasma was taken and an intravenous infusion of normal saline containing 1.5% inulin and 0.15% paraaminohippurate (PAH) was started at a rate of 0.30 ml/min per kg BW. This solution was used during period 2 of groups I, III, IV, and V as a vehicle for the infusion of AVP and/or the pressor antagonist. The protein loss due to surgical manipulation was replaced according to the protocol of Ichikawa et al. (10) modified as follows: bovine serum albumin (Sigma Chemical Co., St. Louis, MO) was dissolved in normal saline to achieve a 5% albumin solution. This solution was infused at a rate of 0.27 ml/min per kg BW for I h and then continued at a rate of 0.033 ml/min per kg BW for the remaining time of the experiment.
Videomicroscopy. The exposed papilla was positioned under the objective of an intravital microscope (E. Leitz, Inc., Rockleigh, NJ). At the end ofthe stabilization period, 0.2 ml of fluorescein isothiocyanate (FITC) gamma globulin was injected intravenously. The preparation of the FITC gamma globulin has been described previously (7) . The papilla was illuminated with fluorescent light (excitation wave length < 490 nm, emission wave length > 530 nm), and the image of the microscopic field was transmitted to a high sensitivity television camera (model 4410 SIT; Cohu Inc., San Diego, CA), displayed on a television monitor, and documented on videotape (7, 8) . 2-3 different areas near the base of the papilla were recorded, each for 3-5 min. A sketch of the field in view was drawn to insure the recording of the same microscopic field subsequently. At the end of each recording a bolus of 0.03-0.05 ml of FITC gamma globulin was injected to highlight the walls of the vasa recta (VR) to facilitate measuring the vessel diameters for a few seconds. The injection had no effect on blood pressure or VR velocity. The final magnification on the monitor screen with an L 20 (E. Leitz, Inc.) objective, without further ocular magnification, was 850-1,150 X, depending on the location on the screen (12).
VR diameter (D). The diameter of a VR was measured as the distance between the fluorescent rims of the capillary walls on the monitor corrected for final magnification on the video screen.
Erythrocyte velocity (VwJ. VR3c was measured by a dual-slit technique from the videotape recordings as described previously (7, 8) . Photometric signals from two nearby sites on the same capillary were analyzed and the transit time of erythrocytes was obtained by a time series cross-correlation of the two signals using an automated digital cross-correlation system. From transit time and real distance between the two sites the VRC was calculated.
Experimental protocols. Five groups of rats were studied. The initial measurements in all groups began 2 h after exposure of the papilla. An outline of the experimental protocol for groups I to IV is given in Fig. 1 The second and third periods in the different groups were conducted as follows:
Group I (n = 8): A VP-induced antidiuresis. Antidiuresis was induced by infusing AVP intravenously at a rate of 45 ng/h per kg BW (9) . The AVP was dissolved in the infusate on the day of the experiment and infused in place of the initial infusion at the same rate (0.30 ml/ min per kg BW). After the AVP infusion began, the glucose-saline infusion through a separate line was gradually reduced during the first 20 min to match the falling urine flow (UF), and was maintained at 0.063 ml/min per kg BW thereafter. 60 min after onset of the AVPinfusion, period 2 began, during which the collection of plasma and urine was obtained as in period 1. Videomicroscopic recordings of the same areas studied in period I were made. In period 3, the glucosesaline solution was restored to the original rate of 0.70 ml/min per kg BW, and the original infusate without AVP was given. Period 3 began 60 min later and was identical to period 1. Group II (n = 8): time control. In this group, the original baseline infusion was maintained and the glucose-saline infusion sustained at the rate of 0.70 ml/min per kg BW throughout all three periods. The periods were otherwise identical in design to that of group I. Concomitantly with the onset of the AVP/antagonist infusion, a precise dose of the antagonist was given 1 ag/h per kg BW in a volume of 2 ml/kg, a protocol similar to that used by Imai et al. (14) . After 60 min, sampling and recording of period 2 was started. Period 3 was identical to period 3 in group I.
Group IV (n = 6): VI-inhibitor alone. The infusion protocol in this group was similar to group II. Glucose-saline infusion was administered at the rate of 0.70 ml/min per kg BW throughout all three periods. The base-line infusion containing the AVP-antagonist used in group III was infused, and the same primary dose as in group III was administered. 60 min later, samples and video recordings were taken. Period 3 was identical to that of group I.
Group V(a) (n = 4) and V(b) (n = 3): effectiveness ofpressor antagonism. Animals were prepared as described before except that the left kidney was not dissected. The animals received the same base-line infusion as groups I-IV. Glucose-saline was infused at 0.70 ml/min per kg BW. 2 h after completion of surgery a bolus of saline (2 ml/kg) was given and the rise in blood pressure noted. 5 min later, AVP was given in a dose of 10 ng/kg (group V[a], n = 4) or 3 ng/kg (group V[b], n = 3) in a volume of 2 ml/kg. The peak of the change in blood pressure immediately after injection was recorded. After the pressure had returned to base line (30 min later), the pressor antagonist was infused as in period 2 of groups III and IV: a bolus of I Ag/kg d(CH2)5Tyr(Me)AVP followed by an infusion of 5 pg/h per kg added to the base-line infusion. 60 min after onset of the antagonist infusion, another bolus of AVP was given in the same two doses and in the same manner as before and the pressure change recorded.
Analyses. Blood pressure was recorded using a Statham strain gauge and recorded on a strip chart recorder (model 110; Gould Inc., Cleveland, OH). Hematocrit (HCT) was determined after centrifugation in a hematocrit centrifuge for 5 min. Plasma and urine osmolality (U.<) were determined by freezing point depression using a Ramsay Brown osmometer (11) . Inulin was determined with the anthrone method (15 (2) Total papillary blood inflow was calculated as the product of average value of QDVR multiplied by the total number of functioning DVR of 906; and total papillary outflow was calculated from QAVR and number of functioning AVR of 2,038. The number of DVR and AVR were obtained from the total number of VR of 2,944 (7) at the base of the exposed papilla, and the functional ratio of AVR to DVR of 2.25 (8) was obtained at the same location. The volume of fluid reabsorbed in the exposed papilla and removed by VR was taken as the difference between inflow and outflow of blood (7, 8) . As carefully delineated by Holliger and his colleagues (7), these calculations incorglucose-saline solution in millimeters per minute per kilogram BW, which was adjusted according to urinary flow. In addition, a base-line infusion of 30 ,I/min per 100 g BW normal saline containing 5% albumin was given. The horizontal axis represents the time scale in minutes.
porate mean values for QDVR and QAVR, and number of DVR and AVR in the papilla. Each of these four mean values has confidence limits such that the upper and lower bounds to the calculated water uptake are relatively far apart (7) . Thus, the calculated values for fluid uptake are meant to infer only the direction of changes.
Statistics. Data are given as mean±SE. Periods 1-3 were compared using paired determinations or nonpaired determinations as appropriate using t test (17) . Statistically significant difference was assumed if the P values were <0.05 (two-tailed t test).
Results
Groups I-IV General parameters. Mean arterial pressure, systemic HCT, and plasma osmolality (Posm) remained unchanged except for a slight fall (3 mmHg) in pressure in the third period in groups I-IV and a slight decline (5 mosM/kg H20) in plasma osmolality in the second period in group II. The BW in groups I-IV was 125±10 g (mean±SEM), 116±9, 124±5, and 135±8, respectively. The mean urine-to-plasma inulin (U/P1.) increased from 9±1 to 60±8 in the experimental period (P < 0.001) and returned to 11±1 in the recovery period in group I. Corresponding values in group III were similar: 9±1 to 63±1 (P < 0.005) to 13±3, respectively. In contrast, the mean U/P1D remained essentially unchanged throughout all three periods in groups II and IV.
In Fig. 4 the clearance of inulin is depicted. No significant changes occurred between periods among any of the groups.
The clearance of PAH (CpAH) was determined in most rats in each group-in group I (n = 7), group II (n = 6), group III (n QVR, VRBC, D, and Qbood ( Group V: verification that A VP pressor effect was inhibited. The degree of inhibition of the vasopressor effect of AVP was studied in group V(a). First a bolus of AVP, 10 ng/kg BW, was administered. Mean arterial pressure increased by 27±3 mmHg. The infusion of the same volume of vehicle (normal saline) alone increased the blood pressure by 1.7±0.6 mmHg. Next the vascular inhibitor VPA was infused for 60 min, after which the pressure response to the same amount of AVP was nearly completely abolished, 4.0±1.6 mmHg, which was significantly different from the first AVP infusion (P < 0.001). In group V(b), the same protocol was followed, except that a lower dose of AVP, 3 ng/kg BW, was injected. The corresponding changes in blood pressure were 12±2 mmHg after AVP, 0.3±0.3 mmHg after the vehicle, and 0.7±0.7 mmHg after the administration of both AVP and the inhibitor VPA, a significantly lower response than that from AVP alone (P < 0.001). Discussion Renal function. The The results clearly demonstrate that during antidiuresis induced by AVP, papillary blood flow is diminished. Moreover, the study demonstrates for the first time that AVP induces a fall in both papillary blood inflow and outflow (see below). Thurau and co-workers (4), who measured medullary blood inflow indirectly by a dye dilution curve, observed that it fell after AVP. A decrease in medullary flow has also been reported by several investigators using indirect techniques (18) (19) (20) (21) . Conversely, either no change or an increase in medullary flow after AVP was found by Aukland (22) (9), several substantive improvements in the videomicroscopy technique were introduced in the present study, as described recently by Holliger and co-workers (7). These methodological improvements enabled us to detect real differences between VRBC in AVR and DVR (7, 8) , whereas in our first study no difference in VRBC between AVR and DVR was demonstrable. Thus it is not surprising that an effect of AVP not demonstrable in our initial study is now clearly detectable in the present experiments. The concentration of AVP in plasma was not determined in this study, but from the amount infused it may be estimated by assuming a biological half-life of -2.5 min in rats and a volume of distribution equal to the extracellular space (27) (28, 29) .
Medullary blood flow increased with time in the control experiments (groups II and IV). This is in agreement with earlier observations that severing the ureter is associated with an increase in medullary plasma flow (9, 30) . The reason for this increase is not clear; a suggestion that release of prostaglandins might play a role (30) has been rejected by another group as an explanation (31) .
The reduction of papillary blood flow found in the present study is qualitatively similar to previous observations (4, 21) , but proportionally much less (Fig. 7) . From the study of Thurau et al. (4) it can be calculated (32) The second consequence that might reduce QVR is that the medullary interstitial concentration of NaCi and urea will likely increase. We have previously found that net fluid removal-not uptake-occurs in DVR, and suggested at the time that the removal is due to a net outward osmotic driving force created by the transcapillary difference in concentration of nonprotein solutes, NaCl and urea (35) . A rise in the medullary interstitial concentration of these solutes is likely to enhance the gradient for water removal from DVR, and thus reduce blood flow.
With the changes in groups I and II as a reference, the findings in group III are critical. The infusion of VPA along with AVP abolished the fall in DVR blood flow (Fig. 6 C) (Fig. 6 B) 36) and is consistent with the morphology of the endothelia of DVR in the renal papilla, which lack smooth muscle cells, and of AVR, which are thin and identical to those of systemic capillaries (37 (38) , nor could Trinh-Trang-Tan (39) , although in the latter study a mean increase of 25% was not significant because of scatter. These apparent differences in experimental findings can be reconciled in the following way. The increase in juxtamedullary glomerular transcapillary hydraulic pressure caused by AVP-induced vasoconstriction of the efferent arteriole or proximal DVR, which would increase juxtamedullary SNGFR, could have been offset by the AVP-induced decrease in the ultrafiltration coefficient (mediated by the V2-receptor) (40) , which would decrease juxtamedullary SNGFR.
